Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/test-epi-composition/ and changes regularly. See the Directory of published versions
Full name:
Authorised dose form:
Legal status of supply:
Domain:
Resource status:
Product classification:
Document Details
Generated Narrative: Bundle TEST PURPOSES ONLY - thalidomide
Language: en
Profile: Bundle - ePI
Final Document at 2022-02-16 13:28:17+0000 by Organization ACME industry for Bundle: identifier = http://ema.europa.eu/identifier#None; type = document; timestamp = 2023-06-27 10:09:22+0000
Document Subject
Generated Narrative: MedicinalProductDefinition mpbeef21509ddc33cff9d4dfa3953f39ff
identifier: http://ema.europa.eu/identifier
/EU/1/22/1676/001
type: Medicinal Product
domain: Human use
status: active
legalStatusOfSupply: Medicinal product subject to medical prescription
name
productName: Thalidomide Lipomed 100 mg coated tablets
type: Full name
part
part: nan
type: Invented name part
part
part: nan
type: Scientific name part
part
part: nan
type: Strength part
part
part: nan
type: Pharmaceutical dose form part
Usages
Country Jurisdiction Language EU EU en
Document Content
Generated Narrative: Composition composition-en-beef21509ddc33cff9d4dfa3953f39ff
Language: en
Profile: Composition (ePI)
identifier: http://ema.europa.eu/identifier
/EU/1/22/1676/001
status: Final
type: Package Leaflet
category: Raw
date: 2022-02-16 13:28:17+0000
author: Organization ACME industry
title: TEST PURPOSES ONLY - thalidomide
Mode | Time |
Official | 2022-02-16 13:28:17+0000 |
What is in this leaflet
What Thalidomide Lipomed is Thalidomide Lipomed contains an active substance called thalidomide. This belongs to a group of medicines which affect how your immune system works.
What Thalidomide Lipomed is used for Thalidomide Lipomed is used with two other medicines called melphalan and prednisone to treat adults with a type of cancer called multiple myeloma. It is used in people who have recently been diagnosed and who have not been prescribed another medicine for their multiple myeloma before who are aged 65 years and over, or aged less than 65 years who cannot be treated with high dose chemotherapy, which can be very difficult for the body to handle.
What is multiple myeloma Multiple myeloma is a type of cancer which affects a certain type of white blood cell, called the plasma cell. These cells collect in the bone marrow and divide out of control. This can damage the bone and kidneys. Multiple myeloma generally cannot be cured. However, the signs and symptoms can be greatly reduced or disappear for a period of time. This is called a remission .
How Thalidomide Lipomed works Thalidomide Lipomed works by helping the body s immune system and directly attacking the cancer. It works in a number of different ways:
You will have been given specific instructions by your doctor, particularly on the effects of thalidomide on unborn babies (outlined in the Thalidomide Lipomed Pregnancy Prevention Programme).
You will have been given an educational brochure for patients by your doctor. Read it carefully and follow the related instructions.
If you do not fully understand these instructions, please ask your doctor to explain them again before you take thalidomide. See also further information in this section under Warnings and precautions
and Pregnancy and breast-feeding .
Do not take Thalidomide Lipomed
Do not take Thalidomide Lipomed if any of the above applies to you. If you are not sure, talk to your doctor or pharmacist before taking Thalidomide Lipomed.
Warnings and precautions
Talk to your doctor, pharmacist or nurse before taking this medicine in the following situations:
For women taking Thalidomide Lipomed Before starting the treatment, you should ask your doctor if you are able to become pregnant, even if you think this is unlikely. Even if you do not have a menstrual bleeding following cancer therapy, you may become pregnant. If you are able to become pregnant:
If you are able to become pregnant, your doctor will record with each prescription that the necessary measures, as outlined above, have been taken.
For men taking Thalidomide Lipomed Thalidomide passes into semen. Therefore, do not have unprotected intercourse, even if you had a vasectomy.
For all patients
Talk to your doctor before taking Thalidomide Lipomed if any of the following apply to you:
Your thyroid function may be checked before you take thalidomide and monitored during treatment.
At any time during or after your treatment, tell your doctor or nurse immediately if you experience: blurred, loss of or double vision, difficulty speaking, weakness in an arm or a leg, a change in the way you walk or problems with your balance, persistent numbness, decreased sensation or loss of sensation, memory loss or confusion. These may all be symptoms of a serious and potentially fatal brain condition known as progressive multifocal leukoencephalopathy (PML). If you had these symptoms prior to treatment with Thalidomide Lipomed, tell your doctor about any change in these symptoms.
Your doctor may check if you have a high total amount of tumour throughout the body, including your bone marrow. This could lead to a condition where the tumours break down and cause unusual levels of chemicals in the body which can lead to kidney failure (this condition is called Tumour Lysis Syndrome) (see also section 4 Possible side effects ).
Your doctor should evaluate if you develop additional types of haematological malignancies (called acute myeloid leukaemia and myelodysplastic syndromes) during your treatment with Thalidomide Lipomed (see also section 4 Possible side effects ).
You must not donate blood during treatment with Thalidomide Lipomed and for at least 7 days after stopping treatment.
If you are not sure if any of the above apply to you, talk to your doctor before taking Thalidomide Lipomed.
Children and adolescents Thalidomide Lipomed is not recommended for use in children and young people under 18 years.
Other medicines and Thalidomide Lipomed Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines obtained without a prescription, including herbal medicines.
Make sure you tell your doctor if you are taking any of the following medicines:
Thalidomide Lipomed with food, drink and alcohol Do not drink alcohol while you are taking Thalidomide Lipomed. This is because alcohol can make you sleepy and Thalidomide Lipomed can make you even sleepier.
Pregnancy and breast-feeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy Thalidomide causes severe birth defects or death to an unborn baby.
You must use one effective method of contraception if you are a woman who is able to become pregnant (see section 2 What you need to know before you take Thalidomide Lipomed ).
You must stop treatment and inform your doctor straight away if
For men taking Thalidomide Lipomed who have a female partner who is able to become pregnant, please see section 2 What you need to know before you take Thalidomide Lipomed . If your partner becomes pregnant whilst you are taking thalidomide, you should inform your doctor immediately.
Breast-feeding Do not breastfeed when taking Thalidomide Lipomed as it is not known if thalidomide is passed into human breast milk.
Driving and using machines Do not drive or use any tools or machines if you experience side effects, such as dizziness, tiredness, sleepiness or blurred vision.
Thalidomide Lipomed coated tablets contain lactose and sucrose If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
Always take Thalidomide Lipomed exactly as your doctor or pharmacist has told you to. Check with your doctor or pharmacist if you are not sure.
How much to take The recommended dose is 200 mg (2 x 100 mg coated tablet) a day for adults aged 75 years and under or 100 mg (1 x 100 mg coated tablet) a day for adults aged over 75 years. However, your doctor will choose the dose for you, monitor your progress and may adjust your dose. Your doctor will tell you how to take Thalidomide Lipomed and for how long you will need to take it (see section 2 What you need to know before you take Thalidomide Lipomed ).
Thalidomide Lipomed is taken daily in treatment cycles, each cycle lasting 6 weeks, in combination with melphalan and prednisone which are taken on Days 1 to 4 of each 6-week cycle.
Taking this medicine
If you take more Thalidomide Lipomed than you should If you take more Thalidomide Lipomed than you should, talk to a doctor or go to a hospital straightaway. If possible, take the medicine pack and this leaflet with you.
If you forget to take Thalidomide Lipomed If you forget to take Thalidomide Lipomed at your regular time
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following side effects may happen with this medicine:
Stop taking Thalidomide Lipomed and see a doctor straight away if you notice the following serious side effects you may need urgent medical treatment:
Tell your doctor straight away if you notice any of the following serious side effects:
Other side effects include:
It is important to note that a small number of patients with multiple myeloma may develop additional types of cancer, especially haematological malignancies, and it is possible that this risk may be increased with Thalidomide Lipomed treatment; therefore, your doctor should carefully evaluate the benefit and risk when you are prescribed Thalidomide Lipomed.
Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Not known (frequency cannot be estimated from the available data)
Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and on the blister after EXP. The expiry date refers to the last day of that month.
Do not use if you notice any damage or signs of tampering.
This medicine does not require any special storage conditions.
At the end of your treatment you should return all unused coated tablets to the pharmacist or doctor. These measures will prevent misuse.
What Thalidomide Lipomed contains
What Thalidomide Lipomed looks like and contents of the pack Thalidomide Lipomed 100 mg coated tablets are white sugar-coated tablets. The coated tablets are supplied in a carton containing 30 coated tablets (3 blisters of 10 coated tablets each).
Marketing Authorisation Holder and Manufacturer Lipomed GmbH Hegenheimer Strasse 2 79576 Weil am Rhein Germany
This leaflet was last revised in .
Other sources of information
Detailed information on this medicine is available on the European Medicines Agency web site:
Entry 1 - fullUrl = Composition/composition-en-beef21509ddc33cff9d4dfa3953f39ff
Resource Composition:
Generated Narrative: Composition composition-en-beef21509ddc33cff9d4dfa3953f39ff
Language: en
Profile: Composition (ePI)
identifier:
http://ema.europa.eu/identifier
/EU/1/22/1676/001status: Final
type: Package Leaflet
category: Raw
date: 2022-02-16 13:28:17+0000
author: Organization ACME industry
title: TEST PURPOSES ONLY - thalidomide
Attesters
Mode Time Official 2022-02-16 13:28:17+0000
Entry 2 - fullUrl = MedicinalProductDefinition/mpbeef21509ddc33cff9d4dfa3953f39ff
Resource MedicinalProductDefinition:
Generated Narrative: MedicinalProductDefinition mpbeef21509ddc33cff9d4dfa3953f39ff
identifier:
http://ema.europa.eu/identifier
/EU/1/22/1676/001type: Medicinal Product
domain: Human use
status: active
legalStatusOfSupply: Medicinal product subject to medical prescription
name
productName: Thalidomide Lipomed 100 mg coated tablets
type: Full name
part
part: nan
type: Invented name part
part
part: nan
type: Scientific name part
part
part: nan
type: Strength part
part
part: nan
type: Pharmaceutical dose form part
Usages
Country Jurisdiction Language EU EU en